Insightec scores positive coverage for essential tremor treatment
Insightec announced today that Humana became the fifth national payor in the U.S. to cover its ultrasound treatment for essential tremor.
Stay updated with breaking news from Exablate Neuro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insightec announced today that Humana became the fifth national payor in the U.S. to cover its ultrasound treatment for essential tremor.
Insightec Ltd. broadened its CE mark approval for the Exablate Neuro, a focused ultrasound platform which treats essential tremors, to allow patients to have their second side treated. With some 60 million people estimated to be affected by essential tremor globally, Insightec hopes that with both sides treated, patients will have full body relief from tremor and therefore be able to resume everyday activities.
/PRNewswire/ -- Insightec, a global healthcare company specialising in MR-guided focused ultrasound (MRgFUS), today announced it has received additional CE...
/PRNewswire/ -- Insightec, a global healthcare company dedicated to using focused ultrasound technology to transform patient care, today announced that Maurice...
Focused ultrasound ablation significantly reduced tremors and improved mobility for patients with PD; the benefits persisted up to a year after treatment.